Skip to main content

Research Repository

Advanced Search

Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope

Toyoda, Task; Armitstead, Zoe; Bhide, Sampada; Engamba, Serge; Henderson, Emma; Jones, Claire; MacKeith, Pieter; Maddock, Janice; Reynolds, Gary; Scrafton, Nicola; Subesinghe, Manil; Subesinghe, Sujith; Twohig, Helen; Mackie, Sarah L; Yates, Max

Authors

Task Toyoda

Zoe Armitstead

Sampada Bhide

Serge Engamba

Emma Henderson

Claire Jones

Pieter MacKeith

Janice Maddock

Gary Reynolds

Nicola Scrafton

Manil Subesinghe

Sujith Subesinghe

Sarah L Mackie

Max Yates



Abstract

The last British Society for Rheumatology (BSR) guideline on PMR was published in 2009. The guideline needs to be updated to provide a summary of the current evidence for pharmacological and non-pharmacological management of adults with PMR. This guideline is aimed at healthcare professionals in the UK who directly care for people with PMR, including general practitioners, rheumatologists, nurses, physiotherapists, occupational therapists, pharmacists, psychologists and other health professionals. It will also be relevant to people living with PMR and organisations that support them in the public and third sector, including charities and informal patient support groups. This guideline will be developed using the methods and processes outlined in the BSR Guidelines Protocol. Here we provide a brief summary of the scope of the guideline update in development.

What does this mean for patients?PMR is a common condition that causes pain, stiffness, fatigue and difficulty in doing everyday activities. PMR is usually treated with glucocorticoids (corticosteroids, 'steroids'). However, the side effects of treatment can cause problems for many patients. Since the publication of the last guideline for PMR, new research has been published. This guideline will provide healthcare professionals and people with PMR with the information they need to reach shared decisions with clinicians about their treatment, based on the best currently available evidence. In order to do this, we have formed a guideline working group and we will follow the BSR's protocol for creating a robust clinical guideline [].

Citation

Toyoda, T., Armitstead, Z., Bhide, S., Engamba, S., Henderson, E., Jones, C., …Yates, M. (in press). Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice, 8(1), Article rkae002. https://doi.org/10.1093/rap/rkae002

Journal Article Type Article
Acceptance Date Dec 28, 2023
Online Publication Date Feb 14, 2024
Deposit Date Feb 26, 2024
Journal Rheumatology Advances in Practice
Print ISSN 2514-1775
Publisher Oxford University Press
Peer Reviewed Peer Reviewed
Volume 8
Issue 1
Article Number rkae002
DOI https://doi.org/10.1093/rap/rkae002
Keywords management, treatment, polymyalgia rheumatica
Public URL https://keele-repository.worktribe.com/output/756329
Publisher URL https://academic.oup.com/rheumap/article/8/1/rkae002/7606885